<?xml version="1.0" encoding="UTF-8"?>
<p id="par0020">A total of 10 microbial isolates comprising of Gram-positive bacteria (
 <italic>Staphylococcus aureus</italic>, 
 <italic>Bacillus subtilis</italic>), Gram-negative bacteria (
 <italic>Escherichia coli</italic>, 
 <italic>Pseudomonas aeruginosa</italic>, 
 <italic>Klebsiella pneumoniae</italic>), yeast (
 <italic>Candida albicans</italic>) and dermatophytic pathogens (
 <italic>Trichophyton schoenleinii, Trichophyton mentagrophytes, Microsporum gypseum, and Microsporum ferugineum</italic>), previously collected from clinical samples in the postgraduate laboratory of the Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, were used in this study. Each of the collected isolates was re-identified and confirmed using the standard protocols as described in the literature [
 <xref rid="bib0095" ref-type="bibr">[19]</xref>, 
 <xref rid="bib0100" ref-type="bibr">[20]</xref>, 
 <xref rid="bib0105" ref-type="bibr">[21]</xref>, 
 <xref rid="bib0110" ref-type="bibr">[22]</xref>, 
 <xref rid="bib0115" ref-type="bibr">[23]</xref>, 
 <xref rid="bib0120" ref-type="bibr">[24]</xref>, 
 <xref rid="bib0125" ref-type="bibr">[25]</xref>].
</p>
